Leef Brands Inc. (LEEEF)
OTCMKTS · Delayed Price · Currency is USD
0.1908
+0.0088 (4.84%)
Aug 5, 2025, 4:00 PM EDT
Kronos Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jul '21 Jul 31, 2021 | 2018 - 2020 |
| 29.98 | 28.5 | 30.61 | 27 | 33.46 | 7.86 | Upgrade | |
Revenue Growth (YoY) | 3.95% | -6.91% | 13.36% | -19.29% | 325.80% | 32.02% | Upgrade |
Cost of Revenue | 21.77 | 19.56 | 20.59 | 17.45 | 25.04 | 5.7 | Upgrade |
Gross Profit | 8.21 | 8.94 | 10.02 | 9.55 | 8.41 | 2.16 | Upgrade |
Selling, General & Admin | 14.05 | 12.29 | 12.88 | 19.23 | 9.25 | 2.4 | Upgrade |
Research & Development | 0.03 | 0.02 | 0.2 | 1.84 | 0.28 | - | Upgrade |
Other Operating Expenses | 0.05 | 0.06 | 1.24 | 0.94 | 0.13 | - | Upgrade |
Operating Expenses | 16.13 | 14.26 | 16.26 | 23.9 | 11.17 | 5.68 | Upgrade |
Operating Income | -7.92 | -5.32 | -6.24 | -14.34 | -2.75 | -3.53 | Upgrade |
Interest Expense | -4.28 | -5.16 | -4.58 | -4.47 | -3.98 | -0.14 | Upgrade |
Interest & Investment Income | - | - | - | - | - | 0 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0 | Upgrade |
Other Non Operating Income (Expenses) | -0.83 | -6.09 | 0.94 | -1.23 | 0.68 | -0.07 | Upgrade |
EBT Excluding Unusual Items | -13.03 | -16.57 | -9.88 | -20.04 | -6.05 | -3.74 | Upgrade |
Merger & Restructuring Charges | - | - | - | -2.05 | - | - | Upgrade |
Impairment of Goodwill | -2.66 | -2.66 | -30.03 | -12.17 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.14 | Upgrade |
Asset Writedown | - | - | - | -1.22 | - | -0.66 | Upgrade |
Other Unusual Items | -2.08 | -2.08 | -0.02 | 10.21 | - | -2.5 | Upgrade |
Pretax Income | -17.77 | -21.31 | -39.93 | -25.26 | -6.05 | -6.77 | Upgrade |
Income Tax Expense | 3.07 | 3.31 | -4.96 | 3.67 | 1.68 | -0.43 | Upgrade |
Net Income | -20.84 | -24.62 | -34.97 | -28.92 | -7.73 | -6.34 | Upgrade |
Net Income to Common | -20.84 | -24.62 | -34.97 | -28.92 | -7.73 | -6.34 | Upgrade |
Shares Outstanding (Basic) | 156 | 143 | 116 | 73 | 5 | 23 | Upgrade |
Shares Outstanding (Diluted) | 156 | 143 | 116 | 73 | 5 | 23 | Upgrade |
Shares Change (YoY) | 31.68% | 22.96% | 58.47% | 1233.79% | -75.97% | 20.91% | Upgrade |
EPS (Basic) | -0.13 | -0.17 | -0.30 | -0.40 | -1.41 | -0.28 | Upgrade |
EPS (Diluted) | -0.13 | -0.17 | -0.30 | -0.40 | -1.41 | -0.28 | Upgrade |
Free Cash Flow | -6.89 | -6.97 | -7.42 | -6.44 | -0.62 | -2.1 | Upgrade |
Free Cash Flow Per Share | -0.04 | -0.05 | -0.06 | -0.09 | -0.11 | -0.09 | Upgrade |
Gross Margin | 27.40% | 31.37% | 32.73% | 35.38% | 25.15% | 27.47% | Upgrade |
Operating Margin | -26.42% | -18.68% | -20.40% | -53.12% | -8.23% | -44.88% | Upgrade |
Profit Margin | -69.51% | -86.41% | -114.24% | -107.11% | -23.11% | -80.72% | Upgrade |
Free Cash Flow Margin | -22.99% | -24.45% | -24.25% | -23.85% | -1.84% | -26.68% | Upgrade |
EBITDA | -5.95 | -3.42 | -4.3 | -12.79 | -1.36 | -1.51 | Upgrade |
EBITDA Margin | -19.84% | -12.02% | -14.05% | -47.35% | -4.07% | -19.24% | Upgrade |
D&A For EBITDA | 1.97 | 1.9 | 1.94 | 1.56 | 1.39 | 2.01 | Upgrade |
EBIT | -7.92 | -5.32 | -6.24 | -14.34 | -2.75 | -3.53 | Upgrade |
EBIT Margin | -26.42% | -18.68% | -20.40% | -53.12% | -8.23% | -44.88% | Upgrade |
Advertising Expenses | - | 0.44 | 0.69 | 0.86 | 0.27 | 0.43 | Upgrade |
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.